retatrutide glp-1 Retatrutide, a GIP, and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Extreme Side Effects Followed Overdose

During follow-up, 915 MACE events occurred

Lets dive into what microdosing weight loss injections really meansplus holistic alternatives that support your health from the inside out

Youll need to share details about your health history, current medications, past weight-loss efforts, and any conditions that could make GLP-1s risky, including thyroid issues, pancreatitis, or gallbladder disease

Oral care, for example, is important to prevent gum disease for GLP-1 users

GLP-1 medications can be genuinely helpful during this transition, but the perimenopause hormonal fluctuations mean thyroid levels may need even more frequent monitoring